Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.

Harish DharmarajanOluleke FaladeStella E LeeEric W Wang

Published in: International forum of allergy & rhinology (2022)

Overall, both therapies are effective at reducing symptoms in patients with CRSwNP according to SNOT-22. Patients treated with dupilumab reported improved olfaction and decreased cough, postnasal drainage, and thick nasal drainage as compared with patients treated with FESS, while patients treated with FESS had a greater reduction in polyp burden.

Keyphrases

chronic rhinosinusitis
ultrasound guided
atopic dermatitis
minimally invasive
coronary artery bypass
surgical site infection
risk factors
combination therapy
physical activity
insulin resistance
sleep quality
acute coronary syndrome
percutaneous coronary intervention
depressive symptoms
smoking cessation